Products
Periodic safety update reports and when they are due. · 5 products
| Product | Active substance | MA number | DLP | PSUR due | Basis | Status | Actions |
|---|---|---|---|---|---|---|---|
| Valerian root dry extract 500 mg tablets | valerian root | PL/H/3391/001 | 18 Mar 2026 | 27 May 2026 | Not required · Art. 16a — traditional herbal registration | No PSUR required | Open: Valerian root dry extract 500 mg tablets |
| Levothyroxine sodium 50 microgram tablets | levothyroxine sodium | PL/H/1128/002 | 1 Jul 2026 | 29 Sept 2026 | EURD list · Sample version | Overdue by 5 days | Open: Levothyroxine sodium 50 microgram tablets |
| Metformin hydrochloride 1000 mg film-coated tablets | metformin | NL/H/2417/001 | 2 Aug 2026 | 11 Oct 2026 | EURD list · Sample version | Due in 7 days | Open: Metformin hydrochloride 1000 mg film-coated tablets |
| Rivaroxaban 20 mg film-coated tablets | rivaroxaban | DE/H/5820/001 | 14 Sept 2026 | 23 Nov 2026 | EURD list · Sample version | Due in 50 days | Open: Rivaroxaban 20 mg film-coated tablets |
| Amlodipine / valsartan 5 mg/80 mg film-coated tablets | amlodipine / valsartan | ES/H/0463/001 | 3 Nov 2026 | 1 Feb 2027 | Condition of the marketing authorisation | Due in 120 days | Open: Amlodipine / valsartan 5 mg/80 mg film-coated tablets |
No archived products